Endocrine therapy for breast cancer: combined treatment with...

Details Endocrine therapy for breast cancer: combined treatment with... Endocrine therapy for breast cancer: combined treatment with...

A - Human Necessities

61

K

A61K 31/343 (2006.01) A61K 31/138 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2356624

Methods and pharmaceutical combinations for inhibiting estrogen-dependent tumors via the co-administration of antiestrogens, including tamoxifen, and alkyl PCDFs.

L'invention concerne des techniques et des combinaisons pharmaceutiques permettant d'inhiber les tumeurs provoquées par les estrogènes via la co-administration d'antiestrogènes, notamment du tamoxifène, et des dibenzofurannes polychlorés alkylés (PCDF).

Affiliated with

Also associated with

Rating

Endocrine therapy for breast cancer: combined treatment with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endocrine therapy for breast cancer: combined treatment with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endocrine therapy for breast cancer: combined treatment with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1937718